Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids

Table 3

Treatment outcomes in two groups.

Outcomes/groups	A		value	B		value
	Before	After		Before	After
AST( U/L)	383.98±289.49	28.61±9.03	0.001	301.05±214.01	20.00±9.40	0.001(0.604)
ALT (U/L)	249.73±192.12	20.46±8.44	0.003	182.05±81.30	20.33±8.01	0.002(0.595)
TB (μmol/L)	25.44±10.99	3.23±1.53	0.005	26.31±10.91	3.40±1.59	0.004(0.192)